ERBB2 and breast carcinoma: The effect of ATO on cell proliferation was investigated using the MTT assay in a panel of 20 breast cancer cell lines representing the 3 major molecular subtypes of breast cancer, luminal (N = 4), HER2-positive (N = 4) and triple-negative (TN) (N = 12).